Xconomy | Seattle - Business + Technology in the Exponential Economy

Biotech, deals, Instruments

CombiMatrix Looks to Hire Banker

Luke Timmerman 8/14/09

CombiMatrix, the Mukilteo, WA-based maker of genetic analysis tools, said this week it intends to hire an investment bank to evaluate options to “unlock shareholder value,” which might mean selling the company, parts of the company, or a finding partnership, according to a statement. CombiMatrix (NASDAQ: CBMX) considers it a good time to evaluate those options because it has more than a year’s worth of cash in the bank, and it hopes to win $36 million in a court judgment. As we described in this profile in June, CombiMatrix is also going through a strategic shift, gearing its tools more toward the market for cancer diagnostics.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.